1. Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer.
- Author
-
Fotiadis CI, Stoidis CN, Spyropoulos BG, and Zografos ED
- Subjects
- Animals, Humans, Treatment Outcome, Anticarcinogenic Agents therapeutic use, Antineoplastic Agents therapeutic use, Colorectal Neoplasms drug therapy, Colorectal Neoplasms prevention & control, Dietary Supplements, Probiotics therapeutic use
- Abstract
Colorectal cancer is the third most common form of cancer. Current treatments are all associated with a high risk of complications and a low success rate. Recently, synbiotics have been proposed as a new preventive and therapeutic option. There is no direct experimental evidence for cancer suppression in humans as a result of the consumption of pro-, pre- or synbiotics. However, there is a wealth of evidence emerging from laboratory studies. The mechanisms by which pro-, pre- and synbiotics may inhibit colon cancer are now beginning to be understood and will be addressed in the present review.
- Published
- 2008
- Full Text
- View/download PDF